Additional file 12: of Efficient identification of neoantigen-specific T-cell responses in advanced human ovarian cancer

Table S1. Clinical demographics of treatment-naĂŻve (including both chemotherapy and immunotherapy) epithelial ovarian cancer patients at the time of primary debulking surgery. Patient identification number, age at diagnosis, tumor histologic type, FIGO stage, debulking status, residual tumor mass after debulking surgery, number of recurrences after primary debulking surgery, and RECIST to frontline chemotherapy after primary debulking surgery. (XLSX 10 kb)

补充表S1. 初治（含化疗与免疫治疗）上皮性卵巢癌患者首次肿瘤细胞减灭术时的临床人口学特征。收录变量包括：患者识别编号、确诊时年龄、肿瘤组织学类型、国际妇产科联盟（FIGO）分期、减瘤术状态、减瘤术后残余肿瘤负荷、首次肿瘤细胞减灭术后复发次数，以及首次肿瘤细胞减灭术后一线化疗的实体瘤疗效评价标准（RECIST）应答情况。（XLSX 10 kb）